Clinical outcomes in peritoneal dialysis with refractory peritonitis: significance of the day 5 cell count.

IF 2.2 4区 医学 Q2 UROLOGY & NEPHROLOGY Clinical and Experimental Nephrology Pub Date : 2024-10-05 DOI:10.1007/s10157-024-02564-w
Ilay Berke, Dilek Barutcu Atas, Murat Tugcu, Hakki Arikan, Arzu Velioglu, Ebru Asicioglu
{"title":"Clinical outcomes in peritoneal dialysis with refractory peritonitis: significance of the day 5 cell count.","authors":"Ilay Berke, Dilek Barutcu Atas, Murat Tugcu, Hakki Arikan, Arzu Velioglu, Ebru Asicioglu","doi":"10.1007/s10157-024-02564-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Peritoneal dialysis-associated peritonitis is a common and severe complication of peritoneal dialysis, associated with high morbidity and mortality. However, there's a lack of research on refractory peritonitis, which is difficult to manage and has a poor prognosis. Our study aimed to investigate factors affecting clinical outcomes in peritoneal dialysis patients with refractory peritonitis over a 12-year period at a medical faculty hospital in Turkey.</p><p><strong>Methods: </strong>We conducted a retrospective study at a single center from January 2009 to December 2020, involving 135 patients with 236 episodes of refractory peritonitis. The average age of the patient cohort was 53.0 ± 15.9 years, and 72 (53.4%) of the patients were male. The leading identified causes of end-stage kidney disease were glomerulonephritis, hypertensive glomerulosclerosis, and diabetic nephropathy. Data on microbiological etiology, dialysate white blood cell counts, and patient demographics were analyzed to identify catheter removal risk factors. Statistical significance was set at p ≤ 0.05.</p><p><strong>Results: </strong>Comparative analysis between patients with and without catheter loss revealed no significant differences in gender, age, presence of diabetes, prior hemodialysis, or duration of peritoneal dialysis. However, multivariate logistic regression analysis showed that a dialysate white blood cell count exceeding 1000/mm<sup>3</sup> on day 5 and hospitalization had a positive association with catheter loss, while the presence of gram-positive bacterial growth had an inverse correlation.</p><p><strong>Conclusion: </strong>Our study shows that fifth-day dialysate white blood cell count predicts refractory peritonitis outcomes. Future research should focus on developing tools to manage catheter removal proactively and enhance patient prognosis.</p>","PeriodicalId":10349,"journal":{"name":"Clinical and Experimental Nephrology","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10157-024-02564-w","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Peritoneal dialysis-associated peritonitis is a common and severe complication of peritoneal dialysis, associated with high morbidity and mortality. However, there's a lack of research on refractory peritonitis, which is difficult to manage and has a poor prognosis. Our study aimed to investigate factors affecting clinical outcomes in peritoneal dialysis patients with refractory peritonitis over a 12-year period at a medical faculty hospital in Turkey.

Methods: We conducted a retrospective study at a single center from January 2009 to December 2020, involving 135 patients with 236 episodes of refractory peritonitis. The average age of the patient cohort was 53.0 ± 15.9 years, and 72 (53.4%) of the patients were male. The leading identified causes of end-stage kidney disease were glomerulonephritis, hypertensive glomerulosclerosis, and diabetic nephropathy. Data on microbiological etiology, dialysate white blood cell counts, and patient demographics were analyzed to identify catheter removal risk factors. Statistical significance was set at p ≤ 0.05.

Results: Comparative analysis between patients with and without catheter loss revealed no significant differences in gender, age, presence of diabetes, prior hemodialysis, or duration of peritoneal dialysis. However, multivariate logistic regression analysis showed that a dialysate white blood cell count exceeding 1000/mm3 on day 5 and hospitalization had a positive association with catheter loss, while the presence of gram-positive bacterial growth had an inverse correlation.

Conclusion: Our study shows that fifth-day dialysate white blood cell count predicts refractory peritonitis outcomes. Future research should focus on developing tools to manage catheter removal proactively and enhance patient prognosis.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
腹膜透析难治性腹膜炎患者的临床疗效:第 5 天细胞计数的意义。
背景:腹膜透析相关腹膜炎是腹膜透析常见的严重并发症,发病率和死亡率都很高。然而,目前缺乏对难治性腹膜炎的研究,因为难治性腹膜炎难以控制且预后较差。我们的研究旨在调查土耳其一家医学院附属医院 12 年间影响难治性腹膜炎腹膜透析患者临床疗效的因素:我们在一个中心开展了一项回顾性研究,研究时间为 2009 年 1 月至 2020 年 12 月,共涉及 135 名患者,236 次难治性腹膜炎发作。患者的平均年龄为(53.0 ± 15.9)岁,其中 72 名(53.4%)患者为男性。终末期肾病的主要病因是肾小球肾炎、高血压性肾小球硬化症和糖尿病肾病。对微生物病因、透析液白细胞计数和患者人口统计学数据进行了分析,以确定拔除导管的风险因素。统计显著性设定为 p≤ 0.05:结果:对导管脱落和导管未脱落患者进行比较分析后发现,他们在性别、年龄、是否患有糖尿病、之前是否进行过血液透析或腹膜透析持续时间等方面没有明显差异。然而,多变量逻辑回归分析表明,第 5 天透析液白细胞计数超过 1000 个/立方毫米和住院与导管脱落呈正相关,而革兰氏阳性细菌生长与导管脱落呈反相关:我们的研究表明,第五天透析液白细胞计数可预测难治性腹膜炎的结局。结论:我们的研究表明,第五天透析液白细胞计数可预测难治性腹膜炎的预后。未来的研究应侧重于开发工具,以主动管理导管拔除并改善患者预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical and Experimental Nephrology
Clinical and Experimental Nephrology UROLOGY & NEPHROLOGY-
CiteScore
4.10
自引率
4.30%
发文量
135
审稿时长
4-8 weeks
期刊介绍: Clinical and Experimental Nephrology is a peer-reviewed monthly journal, officially published by the Japanese Society of Nephrology (JSN) to provide an international forum for the discussion of research and issues relating to the study of nephrology. Out of respect for the founders of the JSN, the title of this journal uses the term “nephrology,” a word created and brought into use with the establishment of the JSN (Japanese Journal of Nephrology, Vol. 2, No. 1, 1960). The journal publishes articles on all aspects of nephrology, including basic, experimental, and clinical research, so as to share the latest research findings and ideas not only with members of the JSN, but with all researchers who wish to contribute to a better understanding of recent advances in nephrology. The journal is unique in that it introduces to an international readership original reports from Japan and also the clinical standards discussed and agreed by JSN.
期刊最新文献
Effect of monoclonal gammopathy in the progression of acute kidney injury and chronic kidney disease: a retrospective observational study. Pharmacological inhibition of the NLRP3 inflammasome attenuates kidney apoptosis, fibrosis, and injury in Dahl salt-sensitive rats. Prospective randomized trial of antibiotic prophylaxis for percutaneous renal biopsy. The estimation of healthcare cost of kidney transplantation in Japan using large-scale administrative databases. The role of C-reactive protein-to-albumin ratio as a prognostic biomarker in patients hospitalized for cardiorenal syndrome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1